Vena caval filters for the prevention of pulmonary embolism

Abstract

PREPIC {published data only} Decousus H. Eight-year follow-up of a randomized trial investigating vena cava filters in the prevention of PE in patients presenting a proximal DVT: The PREPIC trial.

Experience With Vena Cava Filters at a Large Community Hospital and Level-I Trauma Center

“…20 Based on these 2 studies, the review concluded that no recommendations can be made on the basis of these 2 studies, and ACCP guidelines 7 remain valid. 24 In another review involving 37 studies comprising 6834 patients, the rate of PE after IVCF placement was only 1.7%. 13 However, multiple complications were reported, especially with long-term use (>30 days), and mean retrieval rate was found to be only 34%.…”

Experience With Vena Cava Filters at a Large Community Hospital and Level-I Trauma Center

“…20 Based on these 2 studies, the review concluded that no recommendations can be made on the basis of these 2 studies, and ACCP guidelines 7 remain valid. 24 In another review involving 37 studies comprising 6834 patients, the rate of PE after IVCF placement was only 1.7%. 13 However, multiple complications were reported, especially with long-term use (>30 days), and mean retrieval rate was found to be only 34%.…”

Filtro de vena cava inferior, resultados a mediano y largo plazo.

“…La mortalidad relacionada al procedimiento en la literatura es cercana a cero como en el presente estudio. Sin embargo, la mortalidad menor a 30 días puede ser elevada 21,22 , fundamentalmente debido a complicaciones de la enfermedad de base, especialmente por sepsis y falla orgánica múltiple 22 .…”

“…La incidencia de embolia pulmonar recurrente a pesar de la presencia del FVC es de un 5%-10% 22,23 , en el presente estudio fue de un 2,43% (2 casos), aunque es importante considerar que nuestro seguimiento fue clínico, por lo cual es posible en algún paciente la presencia de embolias subclínicas, sólo detectables mediante estudios morfológicos invasivos.…”

“…En nuestro estudio solo evidenció un caso (1,21%) de oclusión de la vena cava inferior, reportándose en la literatura una incidencia entre un 3% y 5% 22,23 . Actualmente, el paciente persiste con edema moderado de extremidades inferiores, manejado con elastocompresión, presentando leve limitación para el desarrollo de sus actividades diarias.…”

Thromboprophylaxis in Head and Neck Microvascular Reconstruction

“…When anticoagulation is precluded, such as in patients with bleeding diathesis, hemorrhagic stroke, or complications of anticoagulation, an IVC filter may play an important role. 86 There is a lack of substantial evidence to show that drugs used to primarily treat local thrombosis (aspirin, dextran) are also able to reduce the risk of DVT/PE as effectively as other thromboprophylactic medications (HSQ, LMWH), especially when utilized in single pharmacotherapy regimens. However, several studies have concluded that a combination of aspirin and a systemic anticoagulant, while effective in DVT prevention, may increase the rate of hematoma.…”

Experience With Vena Cava Filters at a Large Community Hospital and Level-I Trauma Center

“…20 Based on these 2 studies, the review concluded that no recommendations can be made on the basis of these 2 studies, and ACCP guidelines 7 remain valid. 24 In another review involving 37 studies comprising 6834 patients, the rate of PE after IVCF placement was only 1.7%. 13 However, multiple complications were reported, especially with long-term use (>30 days), and mean retrieval rate was found to be only 34%.…”

Filtro de vena cava inferior, resultados a mediano y largo plazo.

“…La mortalidad relacionada al procedimiento en la literatura es cercana a cero como en el presente estudio. Sin embargo, la mortalidad menor a 30 días puede ser elevada 21,22 , fundamentalmente debido a complicaciones de la enfermedad de base, especialmente por sepsis y falla orgánica múltiple 22 .…”

“…La incidencia de embolia pulmonar recurrente a pesar de la presencia del FVC es de un 5%-10% 22,23 , en el presente estudio fue de un 2,43% (2 casos), aunque es importante considerar que nuestro seguimiento fue clínico, por lo cual es posible en algún paciente la presencia de embolias subclínicas, sólo detectables mediante estudios morfológicos invasivos.…”

“…En nuestro estudio solo evidenció un caso (1,21%) de oclusión de la vena cava inferior, reportándose en la literatura una incidencia entre un 3% y 5% 22,23 . Actualmente, el paciente persiste con edema moderado de extremidades inferiores, manejado con elastocompresión, presentando leve limitación para el desarrollo de sus actividades diarias.…”

Thromboprophylaxis in Head and Neck Microvascular Reconstruction

“…When anticoagulation is precluded, such as in patients with bleeding diathesis, hemorrhagic stroke, or complications of anticoagulation, an IVC filter may play an important role. 86 There is a lack of substantial evidence to show that drugs used to primarily treat local thrombosis (aspirin, dextran) are also able to reduce the risk of DVT/PE as effectively as other thromboprophylactic medications (HSQ, LMWH), especially when utilized in single pharmacotherapy regimens. However, several studies have concluded that a combination of aspirin and a systemic anticoagulant, while effective in DVT prevention, may increase the rate of hematoma.…”

Experience With Vena Cava Filters at a Large Community Hospital and Level-I Trauma Center

“…20 Based on these 2 studies, the review concluded that no recommendations can be made on the basis of these 2 studies, and ACCP guidelines 7 remain valid. 24 In another review involving 37 studies comprising 6834 patients, the rate of PE after IVCF placement was only 1.7%. 13 However, multiple complications were reported, especially with long-term use (>30 days), and mean retrieval rate was found to be only 34%.…”

Filtro de vena cava inferior, resultados a mediano y largo plazo.

“…La mortalidad relacionada al procedimiento en la literatura es cercana a cero como en el presente estudio. Sin embargo, la mortalidad menor a 30 días puede ser elevada 21,22 , fundamentalmente debido a complicaciones de la enfermedad de base, especialmente por sepsis y falla orgánica múltiple 22 .…”

“…La incidencia de embolia pulmonar recurrente a pesar de la presencia del FVC es de un 5%-10% 22,23 , en el presente estudio fue de un 2,43% (2 casos), aunque es importante considerar que nuestro seguimiento fue clínico, por lo cual es posible en algún paciente la presencia de embolias subclínicas, sólo detectables mediante estudios morfológicos invasivos.…”

“…En nuestro estudio solo evidenció un caso (1,21%) de oclusión de la vena cava inferior, reportándose en la literatura una incidencia entre un 3% y 5% 22,23 . Actualmente, el paciente persiste con edema moderado de extremidades inferiores, manejado con elastocompresión, presentando leve limitación para el desarrollo de sus actividades diarias.…”

Thromboprophylaxis in Head and Neck Microvascular Reconstruction

“…When anticoagulation is precluded, such as in patients with bleeding diathesis, hemorrhagic stroke, or complications of anticoagulation, an IVC filter may play an important role. 86 There is a lack of substantial evidence to show that drugs used to primarily treat local thrombosis (aspirin, dextran) are also able to reduce the risk of DVT/PE as effectively as other thromboprophylactic medications (HSQ, LMWH), especially when utilized in single pharmacotherapy regimens. However, several studies have concluded that a combination of aspirin and a systemic anticoagulant, while effective in DVT prevention, may increase the rate of hematoma.…”